A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects

Publication date: Available online 21 June 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Dorothy Cheung, Alice Fong, Han Ting Ding, Christopher R. Cabanski, Jianshuang Wang, Yuan Chen, Jim Bush, Jeffrey M. Harris, Lin Pan
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research